medical cannabis
Danish medical cannabis use rises as regulator reports no new safety signals
September 21, 2026Danish Medicines Agency, medical cannabis
Use of medical cannabis increased substantially in Denmark during 2025, while the Danish Medicines Agency reported three suspected adverse-reaction cases …
Medical cannabis formulation kills prostate cancer in laboratory tests
July 19, 2021Sales and Marketing medical cannabis, prostate cancer
Apollon Formularies have announced its medical cannabis formulations were shown to be effective in killing both hormone-resistant and hormone-sensitive prostate …
Medical cannabis formulation kills breast cancer cells in trial
June 28, 2021Sales and Marketing breast cancer, medical cannabis, oncology
UK-based pharma company, Apollon Formularies, have announced that their medical cannabis formulations were successful in killing triple-negative breast cancer (TNBC) …
Medical cannabis more effective painkiller in 86% of chronic pain patients
May 27, 2021medical cannabis
The Medical Cannabis Clinics (TMCC) have released new data from a survey of patients prescribed medical cannabis to treat pain, …
Medical cannabis: Growth by leaps and bounds
October 18, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Canada, Canopy Growth, medical cannabis, pharma
This article follows parts one and two of our trio of in-depth pieces focusing on the growing medical cannabis phenomenon. …
Medical cannabis: Riding the wave
October 16, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kanabo research, medical cannabis, pharma
Following on from our previous piece from Mewburn Ellis on the history of social attitudes towards cannabis, Israel-based Kanabo Research …
Medical cannabis: On to greener pastures?
October 14, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing medical cannabis, medicinal cannabis, pharma
In the first of three articles on the topic, Callum McGuinn, Associate and European Patent Attorney at Mewburn Ellis, explores …
Latest content
Brenntag and dsm-firmenich expand biopharma vitamin partnership
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
